The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines. Instead, drugmakers are developing treatments that can com…
On Friday, BioMarin announced five-year data from a Phase 3 trial for the drugs Pombiliti and Opfolda to treat late-onset Pompe disease, or LOPD. Th…
It's spring, and Australian birds are building their nests. But with what? Alongside grass and twigs, birds are collecting our trash. In 2023, a glob…
New technology from Texas A&M AgriLife Research could be a major step toward bringing disease-resistant peppers and tomatoes to growers' fields and l…
Subscribe our newsletter to stay updated
Thank you for subscribing!